logo_en

International research projects

Pharmine

Faculty of Pharmacy, University of Ljubljana participates in the project of 7th EU Framework Programme PHARMINE (http://www.pharmine.org), established by European Association of Pharmaceutical Faculties (EAFP:http://www.vub.ac.be/MICH/eafp/index.html) with the aim to acquire basic data  important for planning of comparable pharmaceutical education and training in Europe.

In the XXI century EU, pharmacists will play an increasingly important role as partners in the efficient use of the health care resources of the EU (community and hospital pharmacists). They will also be major players in the development of the EU pharmaceutical industry (industrial pharmacists).  Whilst abiding by the recommendations for the duration and course content for EU pharmacy education and training given in the directive 2005/36/EC on the recognition of professional qualifications, PHARMINE will examine the opportunities for the introduction of the principles of the Bologna declaration into pharmacy education and training with the aim of tuning the latter to the future needs in the three areas of pharmaceutical expertise: community, hospital and industrial pharmacy.
The PHARMINE consortium consists of four universities (Brussels, Nancy, London and Lisbon) that are members of the European Association of Faculties of Pharmacy and EU partner associations representing community (Pharmaceutical Group of the European Union), hospital (European Association of Hospital Pharmacists) and industrial (European Industrial Pharmacists Group) pharmacy, together with the European Pharmacy Students' Association and other interested bodies. It will develop a bachelor/master/doctorate system for pharmacy education and training taking into account the need for basic pharmaceutical competences (and mutual recognition of pharmacy qualifications) and the specialization needed in the three main areas of pharmaceutical expertise.

To do this the consortium will survey existing EU pharmacy curricula and attempts to adapt these to the Bologna process (for Slovenia: http://www.pharmine.org/losse_paginas/Country_Profiles/Slovenia/ ). The consortium will then produce a common competency curriculum as well as curricula for specialized pharmacy practice. This will be presented to the EU commission, national authorities and national professional pharmacy bodies. The aim is to put forward an EU standard for pharmacy education and training to be adopted by both the older and newer member states as well as candidates for EU membership and countries in non-EU areas such as Africa, China, India and South America. EAFP will provide advice, quality assurance and approval to countries and higher education institutions wishing to adopt this new EU standard for pharmacy education and training.  http://enzu.pharmine.org/media/filebook/files/PHARMINE_Paradigm.pdf

Faculty of Pharmacy University of Ljubljana takes part in the project as a cooperating member with her experiences introducing Bologna principles including specialized pharmacy practice into curriculum for large classes (>150 students in class) and because of specificity of large share of employing of graduates on field of industrial pharmacy.

NANOPHOTO: Targeted Nanosystems for Improving Photodynamic Therapy and Diagnosis of Cancer

Head: prof. dr. Janko Kos

The researchers of the Programme group Pharmaceutical Biotechnology: Knowledge for Health at the Faculty of Pharmacy, University of Ljubljana participate in the project of 7th EU Framework Programme NANOPHOTO. Other groups are: University of Padova (Italy), University of Groningen (The Netherlands), University College London (Great Britain) and company Biotitec (Jena, Germany). Duration of the project is from 2008 to 2011, the total value is 3.24 milj EUR. The co-ordinator of the project is dr. Elena Reddi from the University of Padova, the head at the Faculty of Pharmacy is prof. Janko Kos.

The overall objective of this project is the development of one or more nanosystems loaded with Foscan® and conjugated to cancer cell specific ligands for improving the efficacy and selectivity of photodynamic therapy (PDT) and to optimise a fluorescence-based tumour imaging approach. A great improvement of the therapy can come from the availability of a carrier able to seek cancer cells and deliver Foscan® selectively to them. Three types of nanosystems, namely, liposomes, silica nanoparticles and poly(lactide-co-glycolide) copolymer nanoparticles, have been selected as potential nanocarriers for the selective delivery of Foscan®. The selection is mainly based on the different chemical nature of these systems, which can affect biocompatibility. During the first part of the project each type of nanosystem will be optimised through in vitro and in vivo tests and leader nanocarriers will be selected and conjugated to cancer cells specific ligands (folic acid, EGF, antibodies) for increasing the selective delivery of Foscan®.